Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

IMPORTANCE: Postmarket safety events of novel pharmaceuticals and biologics occur when new safety risks are identified after initial regulatory approval of these therapeutics. These safety events can change how novel therapeutics are used in clinical practice and inform patient and clinician decisio...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JAMA
Huvudupphovsmän: Downing, Nicholas S., Shah, Nilay D., Aminawung, Jenerius A., Pease, Alison M., Zeitoun, Jean-David, Krumholz, Harlan M., Ross, Joseph S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Medical Association 2017
Ämnen:
Original Investigation
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5815036/
https://ncbi.nlm.nih.gov/pubmed/28492899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2017.5150
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk